CD8A and COVID-19: In COVID-19, ASA-high cells were enriched in CD8 CM, CD8 EM and DN subsets (OR = 4.8, 2.8 and 3.1 respectively, all P < 1 × 10−10), although not in healthy samples, likely reflecting the antiviral response.